InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,509.01
(
0.62%
)
US TECH 100
19,460.00
(
0.95%
)
Dow Jones
39,331.85
(
0.41%
)
Brent Oil
86.36
(
-0.10%
)
Bitcoin
61,946.72
(
-0.14%
)
Post# of 145478
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (5) Keep Next 10 Report Keyboard Shortcuts
Replies (5) Next 10 Prev Next

Sorhay86

Send PM Follow Ignore
Followers 57
Posts 218
Boards Moderated 0
Alias Born 08/22/2018

Sorhay86

Re: Moreyn post# 45494

Tuesday, 10/02/2018 5:16:08 PM

Tuesday, October 02, 2018 5:16:08 PM

Post# of 145478
It is a Reservation of Rights, it won't delay the sale. It seems like a smart, precautionary move.

You have to remember that Mitsui already cut BioAmber a break in 2017. Mitsui's divestiture of their equity stake in the Sarnia Plant joint venture was for $1. This decision followed, what was released as, "a review of corporate strategy". Of course, this also allowed Mitsui to negotiate better terms for the marketing and distribution of BioAmber's bio-succinic. They kept 1.3M shares and currently still hold them.

SS
Public Reply Private Reply New Post
Keep Last Read
Replies (5) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (5) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up